Aptinyx Inc (fka APTX)

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Renee

12/29/23 8:18 AM

Post #30

APTX: effective Jan. 2,2024: Company Dissolved/Final Liquidation.

FINRA will delete the symbol:

https://otce.finra.org/otce/dailyList?viewType=Deletions

Renee

05/18/23 6:37 PM

Post #29

APTX delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions

surf1944

04/19/23 1:01 PM

Post #28

Re: #27: @surf1944 - https://stockcharts.com/h-sc/ui?s=aptx&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://stockcharts.com/h-sc/ui?s=aptx&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/aptx/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/aptx/opinion

Moving again!

surf1944

03/27/23 4:04 PM

Post #27

glenn1919

03/25/23 6:28 AM

Post #26

APTX.............................https://stockcharts.com/h-sc/ui?s=APTX&p=W&b=5&g=0&id=p86431144783

bella99

03/24/23 1:24 PM

Post #25

Re: #24: @BeamMeUpScotty - $50m+ cash in hand so no need for

Looks like offerings going through Now?????????

BeamMeUpScotty Free

03/23/23 6:37 PM

Post #24

Re: #23: @BeamMeUpScotty - Also has huge institutional investors. Takes up two

$50m+ cash in hand so no need for any offerings any time soon. Huge gaps to the up side!

BeamMeUpScotty Free

03/23/23 6:35 PM

Post #23

Re: #22: @MASTERULTRA - NO SHHH... THIS SHIT IS BLOWING UP AND

Also has huge institutional investors. Takes up two pages! See the link.

Scroll all the way down

https://whalewisdom.com/stock/aptx

This patent is for a treatment for depression which unfortunately is suffered by more and more people every year so the potential market is huge.

Link to the patent.

https://data.epo.org/publication-server/pdf-document?pn=3490992&ki=B1&cc=EP

MASTERULTRA Free

03/23/23 6:02 PM

Post #22

Re: #19: @limer814 - Ok shhhhhh

NO SHHH... THIS SHIT IS BLOWING UP AND I AM SURPRISED...

MASTERULTRA Free

03/23/23 6:01 PM

Post #21

Stocktwit blowing this shit up. Over 10mil in buys AH. HOLYSHIT...

BeamMeUpScotty Free

03/23/23 5:35 PM

Post #20

Re: #18: @THEMASTERS_SON - Shhhhh…keep it quiet til AM!!!

Dude if you look at the “tape” there’s a lot of buys still coming in at high of the day after hours!

limer814

03/23/23 4:38 PM

Post #19

Re: #18: @THEMASTERS_SON - Shhhhh…keep it quiet til AM!!!

Ok shhhhhh

THEMASTERS_SON Free

03/23/23 4:31 PM

Post #18

Shhhhh…keep it quiet til AM!!!

willlbone

02/28/23 1:10 PM

Post #17

Lowered my bid
to 10 cents.

mauiguy2

01/16/21 7:04 AM

Post #16

Re: #15: @Moneta Man - It's one of my favorite quotes from Warren

Good day yesterday. Any reason for it?

Moneta Man Free

11/29/20 3:10 PM

Post #15

It's one of my favorite quotes from Warren Buffett, the world's most famous value investor: "Price is what you pay; value is what you get." Get ready to get a whole lot of value with APTX going forward. This stock/company is rich with potential!

Moneta Man Free

11/25/20 1:33 PM

Post #14

Status of each clinical study can be found here... https://www.aptinyx.com/clinical-studies/

Moneta Man Free

11/19/20 4:21 PM

Post #13

https://www.smarteranalyst.com/new-blurbs/aptinyx-aptx-receives-a-buy-from-h-c-wainwright/?mod=mw_quote_news

Moneta Man Free

11/12/20 3:41 PM

Post #12

Hoping to learn more about their clinical trials in progress today after market close...
https://finance.yahoo.com/news/aptinyx-inc-host-earnings-call-201500829.html

Moneta Man Free

11/08/20 4:07 PM

Post #11

Here's a link to the NYX-783 study in Phase II trials:
https://clinicaltrials.gov/ct2/show/NCT04044664?term=NYX-783&rank=1

Moneta Man Free

11/08/20 4:06 PM

Post #10

Here's a link to the NYX-783 study in Phase II trials:
https://clinicaltrials.gov/ct2/show/NCT04044664?term=NYX-783&rank=1

Moneta Man Free

11/08/20 4:04 PM

Post #9

Aptinyx is advancing a leading portfolio of novel CNS therapies - pretty exciting. Here's a link to current Phase II trials in the pipeline:
https://www.aptinyx.com/pipeline/

Moneta Man Free

11/08/20 4:04 PM

Post #8

Aptinyx is advancing a leading portfolio of novel CNS therapies - pretty exciting. Here's a link to current Phase II trials in the pipeline:
https://www.aptinyx.com/pipeline/

ClayTrader Free

10/20/20 5:26 PM

Post #7

* * $APTX Video Chart 10-20-2020 * *

Link to Video - click here to watch the technical chart video

crudeoil24 PremiumMember

10/20/20 8:24 AM

Post #6

Re: #5: @crudeoil24 - New price targets, possibly above $10.00 in the forecast.

APTX > Conference Call Information:

scheduled for 8:30 a.m. ET

To access the live conference call and webcast presentation, please dial (866) 939-3921 (U.S. Toll Free) or (678) 302-3550 (U.S. Toll) and refer to conference ID 49992933. A live audio and webcast presentation will be available on the Investors & Media section of Aptinyx's website at https://ir.aptinyx.com. A replay of the webcast will be archived on Aptinyx's website for 30 days following the event.

crudeoil24 PremiumMember

10/20/20 7:45 AM

Post #5

Re: #2: @crudeoil24 - Aptinyx started at outperform with $7 stock price

New price targets, possibly above $10.00 in the forecast.

Aptinyx started at outperform with $7 stock price target at Wedbush
8:40 am ET September 12, 2019 (MarketWatch)
Share
Print
(END) Dow Jones Newswires

realfast95 Free

10/19/20 5:03 PM

Post #4

bam too da moon

ClayTrader Free

01/17/20 4:02 PM

Post #3

* * $APTX Video Chart 01-17-2020 * *

Link to Video - click here to watch the technical chart video

crudeoil24 PremiumMember

09/13/19 12:06 AM

Post #2

Re: #1: @crudeoil24 - APTX > Aptinyx Inc. is a clinical-stage biopharmaceutical

Aptinyx started at outperform with $7 stock price target at Wedbush
8:40 am ET September 12, 2019 (MarketWatch)
Share
Print
(END) Dow Jones Newswires

September 12, 2019 08:40 ET (12:40 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

crudeoil24 PremiumMember

09/13/19 12:05 AM

Post #1

APTX > Aptinyx Inc. is a clinical-stage biopharmaceutical company. The Company discovers and develops therapies for disorders of the brain and nervous system. The Company has a platform for discovering compounds that work through a mechanism, which includes modulation of the N-methyl-D-aspartate (NMDA) receptor to develop pathways involved with nerve cell communication. The Company's compounds are effective on disease models including, depression, neuropathic pain, migraine, traumatic brain injury and age-induced learning impairment. The Company's compounds facilitate receptor activation without over-activating the receptor. The Company’s lead product candidate is NYX-2925, a treatment for the painful diabetic peripheral neuropathy. It is also developing NYX-783 for the treatment of post-traumatic stress disorder and NYX-458 for Parkinson’s disease cognitive impairment. The Company in partnership with Allergan plc, develops AGN-241751 for major depressive disorder indications.

Aptinyx Inc (fka APTX)

Followers	7	Posters	14
Posts (Today)	0	Posts (Total)	30
Created	09/13/19	Type	Free
Moderators

Moderators' Board Intro has not been added

Board Info

Posts Today	0
Posts (Total)	30
Posters	14
Moderators

New Post

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Aptinyx Inc (fka APTX)

Aptinyx Inc (fka APTX)

Join the InvestorsHub Community

Aptinyx Inc (fka APTX)

Board Info